Search results
Author(s):
H Vernon Anderson
Added:
3 years ago
By now everyone is aware of the involvement of computers in cardiology. This involvement ranges from imaging (image capture, image display, image management), to tabulating simple clinical data items, to enormous electronic health records systems. Computers are the necessary substrate for everything that occurs in cardiology, not to mention all the rest of the healthcare system. However, for a…
View more
Author(s):
Gregg C Fonarow
,
Tariq Ahmad
,
Harriette Van Spall
Added:
1 year ago
Dr Harriette Van Spall (McMaster University, CA) talked with Dr Gregg C Fonarow (University of California, US) and Dr Tariq Ahmad (Yale School of Medicine, US) about the PROMPT-HF trial (NCT04514458) presented first at ACC.22.
PROMPT-HF compared the efficacy of an electronic health record-based alert informing providers about evidence-based medications for HFrEF versus usual care in outpatient…
View more
Author(s):
Rani Upadhyay
,
Alexander G Truesdell
,
Babar Basir
Added:
2 years ago
Dr Alexander G Truesdell (Virginia Heart/Inova Heart & Vascular Institute, Falls Church, VA, US), section editor of the USC Special Focus Issue on Cardiogenic Shock invites the authors of "Current Landscape of Temporary Mechanical Circulatory Support Technology". Dr Rani Upadhyay (Stanford Health Care, Oakland, CA, US) gives a quick overview of the paper. Dr Truesdell asks about the complexities…
View more
Author(s):
Harriette Van Spall
,
Mikhail Kosiborod
Added:
6 months ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF trial (NCT04788511).
Around half of patients with heart failure have heart failure with preserved ejection fraction (HFpEF), and most patients with HFpEF are overweight or obese. Patients with…
View more
Ankur Kalra
Research Area(s) / Expertise:
Author
Author(s):
Nick Curzen
,
Tom Keeble
,
Peter O’Kane
,
et al
Added:
11 months ago
In this roundtable discussion, members of the British Cardiovascular Interventional Society's Out-of-Hospital Cardiac Arrest (OHCA) working group - Dr Peter O'Kane, Prof Nick Curzen, Dr Thomas R Keeble, and Dr Nilesh Pareek - joined forces with Prof Marko Noc, Prof Roxana Mehran, and Dr Dawn Adamson, National Specialty Advisor for Cardiology for NHS England, to distill the key messages of the new…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
2 years ago
In the latest episode View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the hot line and late-breaking trials that will be presented atESC Congress 2021.
What presentations should we look out for this weekend? Get your update on the importance of trials such as GUIDE-HF, MASTER DAPT, TOMAHAWK…
View more
Author(s):
Harriette Van Spall
,
John Spertus
Added:
2 years ago
Late-breaker host Dr Harriette Van Spall (McMaster University, CA) invites PI, Dr John Spertus to discuss the innovative CHIEF-HF clinical trial.
The aim of this study was to determine the superiority of the effectiveness of canagliflozin versus placebo in participants with symptomatic heart failure (HF) in improving the overall Kansas City Cardiomyopathy Questionnaire (KCCQ) Total Symptom Score …
View more
Author(s):
John GF Cleland
Added:
1 year ago
Prof John Cleland (University of Glasgow & Glasgow Royal Infirmary, Glasgow, UK) joined us to talk about heart failure management highlights in 2022 including a new phenotype, HFsnEF; available and new treatment options; news on SGLT2is and more.
Recorded at Heart Failure 2022, Madrid.
Videographer: Tom Green
Editor: Mirjam Boros
View more
Author(s):
Yugo Yamashita
Added:
6 months ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502).
The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients…
View more